Quantitation of iodine-123-β-CIT dopamine receptor uptake in a phantom model

Journal of Nuclear Medicine Technology

Volumn 27, Issue 2, 1999, Pages 117-122

  Leong, L K ^a   O'Connor, M K ^a   Maraganore, D M ^a  

^a MAYO CLINIC   (United States)

Author keywords

Brain phantom; Dopamine receptors; Iodine 123 CIT; SPECT

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE RECEPTOR; IODINE 123; TECHNETIUM 99M;

ARTICLE; COLLIMATOR; CORPUS STRIATUM; DRUG UPTAKE; PHANTOM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN; COCAINE; CORPUS STRIATUM; DOPAMINE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; PHANTOMS, IMAGING; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033034779     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mizukawa K, McGeer EG, McGeer PL. Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease. Alzheimer disease, and neurologically normal controls. Mol Chem Neuropathol. 1993; 18:133-144
2. Haberland N, Hetey L. Studies in postmortem dopamine uptake IL Alterations of the synaptosomal cathecholamine uptake in postmortem brain regions in schizophrenia. J Neural Transm. 1987; 68:303-313
3. 123I]CIT. Eur J Pharmacol. 1991; 200:369-370.
4. 123I]-2beta-carbomethoxy-3beta-(4-iodophenyl)tropane: high affinity SPECT radiotracer of monoamine reuptake sites in brain J Med Chem. 1991; 34:3144-3146
5. Kuikka JT, Bergstrom KA, Vanninen E, et al. Initial experience with single-photon emission tomography using iodine-123-labelled 2beta-carbomethoxy-3beta-(4-iodophenyl)tropane in human brain. Eur J Nucl Med. 1993; 20:783-786.
6. 123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease Ann Neural. 1995; 38:589-598.
7. Ishikawa T, Dhawan V, Kazumata K, et al Comparative nigrostriatal dopaminergic imaging with iodine-123-beta-CIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med. 1996; 37:1760-1765.
8. 123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med. 1997; 24:68-71.
9. Kuikka JT. Quantitation of neuroreceptors: a need to increase imaging resolution [Letter to Ed.]. J Nucl Med 1996; 37:1911-1912.
10. Stodilka RZ, Kemp BJ, Prato FS, Nicholson RL. Importance of bone attenuation in brain SPECT quantification. J Nucl Med 1998; 39:190-197.
11. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978; NS-25:638-642.
12. 123I]beta-CIT. Binding kinetics in the human brain. J Neural Transm. 1993; 94:137-146.
13. Hams CC, Greer KL, Jaszczak RJ, et al. Tc-99m attenuation coefficients in water-filled phantoms determined with a gamma camera. Med Phys. 1984; 11:681-685.
14. Nicholson RL, Doherty M, Wilkins K, Prato FS. Paradoxical effect of the skull on attenuation correction requirements for brain SPECT [Abstract]. J Nucl Med 1988; 29:1316
15. Kemp BJ, Prato FS, Dean GW, et al. Correction for attenuation in technetium-99m-HMPAO SPECT brain imaging. J Nucl Med. 1992; 33:1875-1880.
16. Moore SC, Kouris K, Cullum I. Collimator design for single photon emission tomography. Eur J Nucl Med. 1992; 19:138-150.
17. Jackson GD, Duncan JS MRI Neuroanatomy: A New Angle on the Brain. New York, NY. Churchill Livingstone: 1996:74-90.
18. Kojima A, Matsumoto M, Takahashi M, et al. Effect of spatial resolution on SPECT quantification values. J Nucl Med. 1989; 30:508-514.